Inventor · Cambridge, MA, US

Gary J. Nabel

108Patents
20h-index
108Co-inventors
93Inventor score

Filing activity: Oct 20, 1982 → May 27, 2024

Most-cited inventions

PatentTitleAreaCited byStatus
US5328470A Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor Human Necessities 602 Expired
US6352694B1 Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells Chemistry; Metallurgy 442 Expired
US6534055B1 Methods for selectively stimulating proliferation of T cells Chemistry; Metallurgy 388 Expired
US6905680B2 Methods of treating HIV infected subjects Chemistry; Metallurgy 323 Expired
US6887466B2 Methods for selectively stimulating proliferation of T cells Chemistry; Metallurgy 322 Expired
US6905681B1 Methods for selectively stimulating proliferation of T cells Chemistry; Metallurgy 320 Expired
US5858358A Methods for selectively stimulating proliferation of T cells Chemistry; Metallurgy 299 Expired
US7175843B2 Methods for selectively stimulating proliferation of T cells Chemistry; Metallurgy 286 Expired
US7232566B2 Methods for treating HIV infected subjects Chemistry; Metallurgy 277 Expired
US7144575B2 Methods for selectively stimulating proliferation of T cells Chemistry; Metallurgy 274 Expired
US5698531A Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor Human Necessities 94 Expired
US5324818A Proteins useful in the regulation of .kappa.B-containing genes Chemistry; Metallurgy 69 Expired
US5910488A Plasmids suitable for gene therapy Chemistry; Metallurgy 69 Expired
US8454972B2 Method for inducing a multiclade immune response against HIV utilizing a multigene and multiclade immunogen Chemistry; Metallurgy 46 Active
US5707969A Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor Human Necessities 43 Expired
US5863904A Methods for treating cancers and restenosis with P21 Human Necessities 29 Expired
US9353353B2 Virus-like particles (VLPs) prepared from chikungunya virus structural proteins Emerging Cross-Sectional Technologies 26 Active
US6203991A Inhibition of smooth muscle cell migration by heme oxygenase I Human Necessities 24 Expired
US4559310A Assay methods and systems utilizing mast cell clones Emerging Cross-Sectional Technologies 22 Expired
US7479269B2 Methods for selectively enriching TH1 and TH2 cells Chemistry; Metallurgy 21 Active
US6218372A Methods for treating restenosis with p21 Human Necessities 20 Expired
US9441019B2 Influenza hemagglutinin protein-based vaccines Chemistry; Metallurgy 19 Active
US9487563B2 Virus-like particles and methods of use Emerging Cross-Sectional Technologies 18 Active
US7947822B2 HIV vaccines based on Env of multiple clades of HIV Chemistry; Metallurgy 17 Active
US7094598B2 Development of a preventive vaccine for filovirus infection in primates Chemistry; Metallurgy 17 Expired

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.